May 09, 2025

BAL Guides Treatment in Pediatric Respiratory Illness

BAL detected pathogens in 61% of cases and led to treatment changes in nearly 9 out of 10 immunocompromised children with acute respiratory illness, according to a new 5-year study.

Conexiant

May 09, 2025

Few Patients With STI Receive Recommended Antibiotics: Study

A 5-year national study of over 8,800 cases found that fewer than 40% of patients with gonorrhea and just 14% of those with chlamydia were treated with CDC-recommended antibiotics in U.S. primary care.

Conexiant

May 07, 2025

Dr. Vinay Prasad Shakes Up FDA Leadership

The FDA has appointed Vinay Prasad as its new vaccine chief, shaking up biotech stocks and signaling potential shifts in drug approvals.

Reuters

May 06, 2025

Anemia Linked to Hidden Heart Strain in RA

A new study found that 1 in 3 rheumatoid arthritis patients with normal heart function on standard tests had hidden heart strain detectable only through advanced imaging, with anemia emerging as the strongest predictor.

Conexiant

May 05, 2025

Ustekinumab Biosimilar Receives Interchangeability Approval

Selarsdi (ustekinumab-aekn) was approved by the FDA as an interchangeable biosimilar to Stelara (ustekinumab) for all approved indications, including psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.

Conexiant

May 05, 2025

FDA Monthly Round-up: Key April Updates

April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.

Conexiant

May 01, 2025

Health Care Shortage: Who’s Left Out?

“The ER then says, ‘OK, you should follow up with your primary care provider,’ and they’re like, ‘We don’t have one.’”

KFF Health News

April 30, 2025

FDA Approves FcRn Blocker for Broad gMG Use

The first FcRn blocker for both adult and pediatric generalized myasthenia gravis has been approved by the FDA, based on data showing sustained symptom improvement and IgG reduction in clinical trials.

Conexiant

April 30, 2025

Childhood Wheeze May Be Tied to Ozone Levels

Early-life ozone exposure was linked to increased odds of asthma and wheeze in children aged 4 to 6 years.

Conexiant